Back

Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants

European Heart Journal

4 August 2021
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Stroke Atrial Fibrillation (AF) Pharmacology and Pharmacotherapy

Contributors

Peter Vibe Rasmussen
Peter Vibe Rasmussen

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

Elaine Hylek
Elaine Hylek

Author

You may be interested in
thumbnail
Congress Presentation
Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program
26 August 2023
thumbnail
Congress Session
How to improve outcome of patients with atrial fibrillation?
1 April 2025
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
31 March 2025
thumbnail
Webinar
How to improve patient compliance necessitating oral anticoagulation due to nonvalvular atrial fibrillation
18 November 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources